These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30076959)

  • 1. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Mika J
    Data Brief; 2018 Dec; 21():1145-1150. PubMed ID: 30456228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-
    Piotrowska A; Ciapała K; Pawlik K; Kwiatkowski K; Rojewska E; Mika J
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine CXCL10/CXCR3 signaling contributes to neuropathic pain in spinal cord and dorsal root ganglia after chronic constriction injury in rats.
    Chen Y; Yin D; Fan B; Zhu X; Chen Q; Li Y; Zhu S; Lu R; Xu Z
    Neurosci Lett; 2019 Feb; 694():20-28. PubMed ID: 30448292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay.
    Jopling LA; Watt GF; Fisher S; Birch H; Coggon S; Christie MI
    Br J Pharmacol; 2007 Dec; 152(8):1260-71. PubMed ID: 17982480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
    Front Immunol; 2019; 10():2198. PubMed ID: 31616413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
    Front Immunol; 2021; 12():781310. PubMed ID: 34795678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of iron responsive element (-) divalent metal transporter 1-mediated the spinal iron overload via CXCL10/CXCR3 pathway in neuropathic pain in rats.
    Xu W; Liu W; Yu W
    Neurosci Lett; 2019 Feb; 694():154-160. PubMed ID: 30521948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury.
    Wu XB; He LN; Jiang BC; Shi H; Bai XQ; Zhang WW; Gao YJ
    Mol Pain; 2018; 14():1744806918777401. PubMed ID: 29712506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoted Interaction of C/EBPα with Demethylated Cxcr3 Gene Promoter Contributes to Neuropathic Pain in Mice.
    Jiang BC; He LN; Wu XB; Shi H; Zhang WW; Zhang ZJ; Cao DL; Li CH; Gu J; Gao YJ
    J Neurosci; 2017 Jan; 37(3):685-700. PubMed ID: 28100749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.
    Jurga AM; Rojewska E; Piotrowska A; Makuch W; Pilat D; Przewlocka B; Mika J
    Neural Plast; 2016; 2016():5238730. PubMed ID: 26962463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
    Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
    Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL10/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice.
    Kong YF; Sha WL; Wu XB; Zhao LX; Ma LJ; Gao YJ
    Neurosci Bull; 2021 Mar; 37(3):339-352. PubMed ID: 33196963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.
    Pilat D; Piotrowska A; Rojewska E; Jurga A; Ślusarczyk J; Makuch W; Basta-Kaim A; Przewlocka B; Mika J
    Mol Cell Neurosci; 2016 Mar; 71():114-24. PubMed ID: 26763728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.